Nanjing, China, September 2025 — WixBio’s Overseas Business and Technical Departments recently hosted a face-to-face technical exchange meeting in Nanjing with representatives from UNIVET, a partner company from Kazakhstan. The discussions focused on critical technical aspects, including testing methodologies for poultry vaccines, epidemiological compatibility of vaccine strain subtypes, and adaptability to regional conditions.
The meeting aimed to optimize the performance of WixBio’s vaccine products in the Central Asian market, ensuring consistent and effective immune protection across diverse climatic and farming environments. WixBio’s technical team provided a detailed overview of the company’s processes and quality control standards for vaccine antigen preparation, potency testing, specific pathogen-free (SPF) chicken embryo virus titration, and hemagglutination inhibition (HI) antibody monitoring. Additionally, they outlined the company’s approach to strain selection and updates based on country-specific epidemiological data.
Given the recent prevalence of 鳥インフルエンザ (H9N2), Newcastle disease (G-7 strain), 、および 伝染性気管支炎 in Kazakhstan, both parties thoroughly evaluated the compatibility of existing vaccine combinations. They also reached a preliminary agreement on the future development of customized multivalent vaccines. WixBio highlighted its robust customization capabilities, enabling rapid adjustments to vaccine formulations to deliver tailored disease prevention strategies, aligning with a “one country, one strategy; one region, one solution” approach.
UNIVET representatives commended WixBio’s technical expertise and responsiveness, stating, “This in-depth exchange has strengthened our confidence in a long-term partnership with WixBio. Their products have demonstrated outstanding immunogenicity and stability in Kazakhstan, earning widespread approval from local farmers and regulatory authorities.”
この南京での会議は、技術協力を強化しただけでなく、WixBioの中央アジアにおけるプレゼンス拡大に向けた強固な基盤を築きました。WixBioは、高度な研究開発力とグローバルなサービス基盤を活かし、製品のカスタマイズ、技術サポート、アフターサービスを含む包括的な動物保健ソリューションを世界中のお客様に提供することに引き続き注力しています。
